| Table 1. Baseline characteristics and stimulation results for the oocyte donors. | ||
| Group 1 r-hFSH:r-hLH (2:1) (n=39) |
Group 2 HP-hMG (n=40) |
|
|---|---|---|
| Age, years | 24.0 (2.6) 18-30 |
24.2 (2.9) 19-29 |
| AMH, ng/mL | 4.3 (1.7) 2.1-11.8 |
4.5 (2.1) 2.3-11.8 |
| BMI, k/m2 | 22.6 (18.9) 18.9-26.3 |
22.7 (2.1) 18.7-25.7 |
| Weight, kg | 58.9 (6.9) 46.0-77.5 |
58.7 (7.8) 45-77 |
| Height, m | 1.6 (0.1) 1.52-1.77 |
1.6 (0.1) 1.52-1.77 |
| TSH, mIU/L | 1.8 (0.9) 0.8-4.5 |
1.7 (0.7) 0.8-4.0 |
| Prolactin, ng/mL | 15.6 (7.3) 1.9-29.9 |
15.6 (6.3) 6.9-29.6 |
| Total dose, IU | 2140 (205) 1800-2700 |
2120 (227) 1800-3150 |
| Length of stimulation, days | 9.5 (0.9) 8-12 |
9.4 (1.0) 8-14 |
| Oocytes recovered | 22.8 (10.4) 9-57 |
22.4 (10.3) 6-51 |
Data presented as mean (SD), min-max.
AMH, Anti-Müllerian Hormone. BMI, body mass index. HP-hMG, highly purified human menopausal gonadotropin. IU, international units. SD, standard deviation. r-hFSH, recombinant human follicle stimulating hormone, r-hLH, recombinant human luteinising hormone. TSH, thyroid stimulating hormone.